Trials

The stop-GIST-trial: Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor that has become radiologically undetectable with treatment. A prospective multicenter phase II trial

Cancer type: Gastric cancer

Phase: II

Principal Investigator: Joensuu Heikki

Country: FI

Keywords: Finland, Helsinki

Status: Open for inclusion